#OSCC
Check how this study establishes YTHDF2 as a multifunctional oncogene in OSCC, driving tumor aggressiveness through dual mechanisms: 1) enhancing the invasive and metastatic potential of OSCC cells, and 2) promoting lymphangiogenesis and lymphatic endothelial cell migration.
November 17, 2026 at 9:17 AM
Researchers report that chronic stress accelerates oral squamous cell carcinoma (OSCC) by activating the hypothalamic–pituitary–bone marrow (HPB) axis and remodeling the tumor immune microenvironment.
#OSCC #HPB
Details: doi.org/10.1038/s413...
November 12, 2026 at 8:33 AM
Stopping cancer spread requires understanding what drives metastasis.
TMEM242 promotes #LymphNodeMetastasis in #OSCC by driving #EMT and immune evasion, highlighting a promising biomarker and therapeutic target for metastatic disease.
#GenesAndDiseases: doi.org/10.1016/j.ge...
November 10, 2026 at 1:01 PM
My friend Kenney; please help if you can. Thank you.
gofund.me/3bd715dc0
Donate to Support Kenney Through Cancer Treatment, organized by Kenney Martin
Hello. My name is Kenney Martin, and I was diagnosed with cancer stage 3 (OSCC… Kenney Martin needs your support for Support Kenney Through Cancer Treatment
gofund.me
November 8, 2026 at 12:16 AM
Ja, sehr spannend. Hab' das jetzt nur ganz quick & dirty überflogen. In der Studie waren nur OSCC-Patient*innen. Diejenigen mit durchlaufener Infektion hatten danach eine größere Biomarker-Konzentration einer bestimmten Art. Mit der Interpretation muss man da wohl vorsichtig sein. Die Entwicklung
October 27, 2026 at 11:59 AM
Projet de loi « casseurs-payeurs » : pourquoi le texte fait débat au Sénat ? | Presse Océan
➡️ https://l.ouest-france.fr/osCc
#Nantes
October 27, 2026 at 1:09 PM
Gastric and oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. www.annalsofoncology.org/article/S092...
Gastric and oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Gastric and oesophageal cancers differ in histology, epidemiology, risk factors and treatment. For this guideline, we primarily distinguish between oesophageal squamous-cell carcinoma (OSCC) and gastr...
www.annalsofoncology.org
October 23, 2026 at 10:16 AM
A study in Biomarker Research highlights the clinical utility of multigene assay qMIDSV3 as a triage test, sparing most of the oral potentially malignant disorder patients from unnecessary invasive tissue biopsies while accurately identifying oral squamous cell carcinoma cases.

#OncoSky
INHBA–S100A16 dysregulation enables a non-invasive molecular stratification platform for rapid detection of oral squamous cell carcinoma: results from a large diagnostic case-control study - Biomarker Research
Background Early diagnosis of oral squamous cell carcinoma (OSCC) is critical, yet most oral potentially malignant disorders (OPMDs) are benign, and patients frequently undergo unnecessary invasive scalpel biopsies, creating diagnostic delays and patient harm. A rapid, non-invasive molecular diagnostic tool could improve early detection and reduce unnecessary procedures. This study aims to determine whether a previously validated microbiopsy-based multigene assay (qMIDSV2) could be adapted into a rapid, non-invasive brush biopsy test (qMIDSV3) for accurate OSCC detection. A prespecified hypothesis was that qMIDSV3 could distinguish OSCC from low-risk OPMD and contralateral normal mucosa with high diagnostic sensitivity. Methods This prospective diagnostic case-control study validated a multigene mRNA test (qMIDSV3) for OSCC detection using 1090 oral brush biopsies from 545 patients. Each patient provided paired brush biopsies from oral lesion and contralateral non-lesion mucosa, including OSCC (n = 443), oral leukoplakia (OL; n = 63), and oral lichen planus (OLP; n = 39). qPCR quantified mRNA levels of four genes (INHBA, S100A16, YAP1, POLR2A) from each brush biopsy, and an algorithm generated a malignancy index for cancer risk stratification. Results qMIDSV3 distinguished OSCC from OL and OLP with AUC 0.975, sensitivity 95.7%, specificity 95.1%, and overall accuracy 95.5%. False-positive and false-negative rates were 4.9% and 4.3%, demonstrating high specificity for detecting malignant cells rather than premalignant or inflammatory lesions. Conclusions Our findings highlight the clinical utility of qMIDSV3 as a rapid case-finding or triage test, potentially sparing over 90% of low-risk OPMD patients from unnecessary invasive tissue biopsies while accurately identifying OSCC cases. Non-invasive brush biopsy allows safe, repeatable sampling for long-term surveillance with minimal patient harm and enhancing early oral cancer detection. By reducing unnecessary scalpel biopsies and specialty referrals, qMIDSV3 provides a molecularly guided and rapid triage pathway.
bit.ly
October 21, 2026 at 8:40 PM
arXiv paper introduces OSCC, a framework for coupling counterfactual rollouts in imperfect-information learning that enforces hidden-state and chance-event safety while accounting for return-covariance geometry in policy gradients.

#cybersecurity #AI #AIresearch
https://arxiv.org/abs/2609.33543
October 19, 2026 at 8:01 PM
ナショナル・シアターライブ『危険な関係』

🎦大阪ステーションシティシネマ
10/16(金)〜10/22(木)
全日17:30~20:30
www.osakastationcitycinema.com/site/oscc/de...
大阪ステーションシティシネマ
大阪府大阪市の映画館・シネコン【大阪ステーションシティシネマ】。上映スケジュール、施設案内、前売券・料金・アクセスの紹介、インターネットチケット購入のご案内。
www.osakastationcitycinema.com
October 13, 2026 at 2:25 AM
A study in Biomarker Research highlights the clinical utility of multigene assay qMIDSV3 as a triage test, sparing most of the oral potentially malignant disorder patients from unnecessary invasive tissue biopsies while accurately identifying oral squamous cell carcinoma cases.

#OncoSky
INHBA–S100A16 dysregulation enables a non-invasive molecular stratification platform for rapid detection of oral squamous cell carcinoma: results from a large diagnostic case-control study - Biomarker Research
Background Early diagnosis of oral squamous cell carcinoma (OSCC) is critical, yet most oral potentially malignant disorders (OPMDs) are benign, and patients frequently undergo unnecessary invasive scalpel biopsies, creating diagnostic delays and patient harm. A rapid, non-invasive molecular diagnostic tool could improve early detection and reduce unnecessary procedures. This study aims to determine whether a previously validated microbiopsy-based multigene assay (qMIDSV2) could be adapted into a rapid, non-invasive brush biopsy test (qMIDSV3) for accurate OSCC detection. A prespecified hypothesis was that qMIDSV3 could distinguish OSCC from low-risk OPMD and contralateral normal mucosa with high diagnostic sensitivity. Methods This prospective diagnostic case-control study validated a multigene mRNA test (qMIDSV3) for OSCC detection using 1090 oral brush biopsies from 545 patients. Each patient provided paired brush biopsies from oral lesion and contralateral non-lesion mucosa, including OSCC (n = 443), oral leukoplakia (OL; n = 63), and oral lichen planus (OLP; n = 39). qPCR quantified mRNA levels of four genes (INHBA, S100A16, YAP1, POLR2A) from each brush biopsy, and an algorithm generated a malignancy index for cancer risk stratification. Results qMIDSV3 distinguished OSCC from OL and OLP with AUC 0.975, sensitivity 95.7%, specificity 95.1%, and overall accuracy 95.5%. False-positive and false-negative rates were 4.9% and 4.3%, demonstrating high specificity for detecting malignant cells rather than premalignant or inflammatory lesions. Conclusions Our findings highlight the clinical utility of qMIDSV3 as a rapid case-finding or triage test, potentially sparing over 90% of low-risk OPMD patients from unnecessary invasive tissue biopsies while accurately identifying OSCC cases. Non-invasive brush biopsy allows safe, repeatable sampling for long-term surveillance with minimal patient harm and enhancing early oral cancer detection. By reducing unnecessary scalpel biopsies and specialty referrals, qMIDSV3 provides a molecularly guided and rapid triage pathway.
bit.ly
October 4, 2026 at 7:00 PM
METTL14-mediated m6A modification of CXCL9 mRNA regulates macrophage CS polarization to suppress OSCC growth and stemness

Functional & integrative genomics · Yang et al.
doi.org/10.1007/s10142-026-02053-1
#RNAsky #RNAmods
METTL14-mediated m6A modification of CXCL9 mRNA regulates macrophage CS polarization to suppress OSCC growth and stemness
Functional & integrative genomics · Yang B, Liu F, Qiu Y, Wu W, Zhang H, Tan H, Jiang C.
doi.org
October 3, 2026 at 11:27 PM
Development of a clinical prediction model using volatile organic compounds as breath biomarkers in squamous oesophageal neoplasms: ViSON, protocol for a multicentre case–control study in UK NHS hospitals. @velindrecc.bsky.social bmjopen.bmj.com/content/16/9...
Development of a clinical prediction model using volatile organic compounds as breath biomarkers in squamous oesophageal neoplasms: ViSON, protocol for a multicentre case–control study in UK NHS hospi...
Introduction Oesophageal squamous cell carcinoma (OSCC) accounts for more than 85% of the global burden of oesophageal cancer, resulting in 500 000 deaths annually. In the UK, over two-thirds of OSCC ...
bmjopen.bmj.com
October 2, 2026 at 8:52 AM
OSCC: Certified Observation-Safe Coupling Optimization for Gradient-Noise Control in Imperfect-Information Learning
Read more: https://arxiv.org/html/2609.33543v1
October 2, 2026 at 2:42 AM
Using spatial transcriptomics, we characterized the molecular and microenvironmental changes associated with the progression of oral epithelial dysplasia (OED) to oral squamous cell carcinoma (OSCC).
#SpatialTranscriptomics #Cancer #OralPathology #CancerResearch aacrjournals.org/mcr/article-...
Spatial transcriptomic analysis of progressing oral epithelial dysplasia reveals unique differentially expressed genes and microenvironmental changes.
Abstract. Oral squamous cell carcinoma (OSCC) often arises from oral epithelial dysplasia (OED); however, the gene expression changes during OED progression and its microenvironment are not fully unde...
aacrjournals.org
October 1, 2026 at 2:40 AM
Hu, Hu, Guo, Wang, Wang, Chen, Zha, Xiao: OSCC: Certified Observation-Safe Coupling Optimization for Gradient-Noise Control in Imperfect-Information Learning https://arxiv.org/abs/2609.33543 https://arxiv.org/pdf/2609.33543 https://arxiv.org/html/2609.33543
September 29, 2026 at 6:42 AM
Can a simple saliva test predict oral cancer risk with near-perfect accuracy? A new machine learning model achieved a striking 0.997 testing R2 score by combining lifestyle factors and salivary biomarkers to map oral squamous cell carcinoma (OSCC) risk.
AI predicts oral cancer risk using saliva
A new neural network detects oral cancer risk with near-perfect accuracy, but its real value lies in exposing how lifestyle habits and biology collide.
yesilscience.com
September 24, 2026 at 5:01 PM
PIAS1 loss and INHBA gain define a TGFβ-driven EMT state in OSCC progression #SingleCell 🧪🧬🖥️
https://www.biorxiv.org/content/10.64898/2026.09.18.752768v1
September 22, 2026 at 1:00 PM
PIAS1 loss and INHBA gain define a TGFβ-driven EMT state in OSCC progression https://www.biorxiv.org/content/10.64898/2026.09.18.752768v1
September 22, 2026 at 11:46 AM
PIAS1 loss and INHBA gain define a TGFβ-driven EMT state in OSCC progression https://www.biorxiv.org/content/10.64898/2026.09.18.752768v1
September 22, 2026 at 11:46 AM
🧬 Could oxidative stress hold the key to better oral cancer care? This review explores ROS-driven OSCC progression, promising biomarkers for early detection, and melatonin as a potential adjunct therapy. 🔬 #OralCancer #OxidativeStress
mdpi.com/2227-9059/12...
September 21, 2026 at 1:48 AM
🌾 Nuakhai is a celebration of gratitude, togetherness and Odisha’s rich roots. As students, may we carry that spirit forward—learn from our roots, grow together and build a better tomorrow.

Nuakhai Juhar! 🌾❤️

#Nuakhai #Odisha #OSCC
September 16, 2026 at 3:30 AM